ALERS — Eurobio Scientific SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €161.64m
- €198.01m
- €152.61m
- 61
- 73
- 38
- 60
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.77 | 3.15 | 73.5 | 60.5 | 24.9 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.784 | 0.862 | 0.92 | 0.455 | -1.25 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.71 | -2.43 | -28.3 | -3.67 | 8.84 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.523 | 4.99 | 54.9 | 65.9 | 43.1 |
Capital Expenditures | -1.63 | -1.59 | -2.3 | -1.85 | -2.83 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.082 | -2.79 | -1.69 | -3.62 | -139 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.55 | -4.39 | -3.98 | -5.47 | -142 |
Financing Cash Flow Items | -2.48 | -1.43 | -2.4 | -0.882 | -1.21 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.27 | -4.01 | 7.05 | -23.8 | 82.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.785 | -3.39 | 57.9 | 36.8 | -16.5 |